Zdrowie i gospodarka · 06/11/2013

FDA Announces Public Meeting on Patient-Focused Drug Development for Sickle Cell Disease

The FDA is hosting a public meeting to gather patients' perspectives on sickle cell disease and its treatment options, as part of its commitment to improve patient outcomes under the Prescription Drug User Fee Act (PDUFA V).